These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32940591)

  • 1. Managing Patients at Risk of Medication Related Complications Requiring Dental Extractions in Primary Care.
    Toole J; McKenna G; Smyth J
    Prim Dent J; 2020 Sep; 9(3):54-58. PubMed ID: 32940591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both non-surgical dental treatment and extractions increase the risk of medication-related osteonecrosis of the jaw: case-control study.
    McGowan K; Ware RS; Acton C; Ivanovski S; Johnson NW
    Clin Oral Investig; 2019 Nov; 23(11):3967-3975. PubMed ID: 30747305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontal Disease, Dental Implants, Extractions and Medications Related to Osteonecrosis of the Jaws.
    Shah NP; Katsarelis H; Pazianas M; Dhariwal DK
    Dent Update; 2015 Nov; 42(9):878-80, 883-4, 887-89. PubMed ID: 26749795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review.
    Diniz-Freitas M; Limeres J
    Med Oral Patol Oral Cir Bucal; 2016 Mar; 21(2):e250-9. PubMed ID: 26827065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays.
    Damm DD; Jones DM
    Gen Dent; 2013 Aug; 61(5):33-8. PubMed ID: 23928436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
    Schwartz S; Joseph C; Iera D; Vu DD
    J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
    Ferlito S; Liardo C; Puzzo S
    Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risk of Medication-Related Osteonecrosis of the Jaw After Dental Extraction is Higher for Patients on Intravenous as Compared With Oral Antiresorptive Drugs.
    Abt E
    J Evid Based Dent Pract; 2017 Jun; 17(2):105-106. PubMed ID: 28501053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Root canal therapy for the prevention of osteonecrosis of the jaws: an evidence-based clinical update.
    Kyrgidis A; Arora A; Lyroudia K; Antoniades K
    Aust Endod J; 2010 Dec; 36(3):130-3. PubMed ID: 21140589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
    Hay KD; Bishop PA
    N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner.
    McLeod NM; Davies BJ; Brennan PA
    Br Dent J; 2007 Dec; 203(11):641-4. PubMed ID: 18065983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: surgical protocol supported by low-level laser therapy.
    Vescovi P; Giovannacci I; Merigo E; Meleti M; Manfredi M; Fornaini C; Nammour S
    J Craniofac Surg; 2015 May; 26(3):696-9. PubMed ID: 25915674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Antiresorptive Agent-Related Osteonecrosis of the Jaw After Dental Implant Removal: A Case Report.
    Yamamoto S; Maeda K; Kouchi I; Hirai Y; Taniike N; Yamashita D; Imai Y; Takenobu T
    J Oral Implantol; 2018 Oct; 44(5):359-364. PubMed ID: 29870295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for treating patients taking bisphosphonates prior to dental extractions.
    Rogers S; Rahman N; Ryan D; Flint S; Healy C; Stassen LF
    J Ir Dent Assoc; 2010; 56(1):40. PubMed ID: 20337145
    [No Abstract]   [Full Text] [Related]  

  • 17. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm.
    Malden N; Beltes C; Lopes V
    Br Dent J; 2009 Jan; 206(2):93-8. PubMed ID: 19165270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.